A seasoned Global Healthcare Leader, Anh has a 15-year track record of driving excellence and transformation in Market Access for pharmaceuticals, medical devices and diagnostics. Known for establishing strategic multi-stakeholder partnerships, Anh has shaped access policies, built the Market Access function from the ground up, established strategic multi-stakeholder partnerships, transformed clinical practices, for earlier/optimised patient access to innovations.

In particular, she has played a key role in shaping market access policies for digital health with the very first APAC recommendation paper on the evaluation and reimbursement of Digital Health Technologies. As Founding Chair of the APACMed Digital Health Committee Reimbursement Workgroup, she successfully drove the industry engagement with policymakers and payers in the Asia-Pacific region, resulting in the Digital Health Reimbursement Alliance creation.

Anh held leadership positions in Abbott and Johnson & Johnson in APAC, and at the French Health Safety Agency (ANSM). She is currently Strategic Advisor for APACMed (Asia-Pacific Medical Technology Association).

Her contributions to the field have been widely recognized, and she has been a regular speaker at major international conferences, providing valuable insights on topics such as digital health, health data, access and reimbursement.

She has been recognised as a LinkedIn Top Voice in Healthcare Management.